SOTK 7/21/2023 Shareholder/Stockholder Letter Transcript:
2023 ANNUAL REPORT
NOVOCOAT IS A 3-AXIS AUTOMATED MOTION COATING PLATFORM SERIES DEVELOPED IN 2022
1975
We continue to innovate and expand our capabilities with fully
engineered solutions designed and built exclusively by our
engineering team, including proprietary application expertise.
Pictured is the NovoCoat coating system, developed in 2022.
Cash, Cash Equivalents &
Marketable Securities
$ in Millions
Stockholders Equity
$ in Millions
Total Debt
$ in Millions
*Does not include $1M PPP loan, forgiven in Q1 FY2022
The charts above demonstrate the financial success that has resulted from Sono-Tek s strategy of diversification
of markets, products and geography. This has led to the ongoing development of an expanded line of ultrasonic
coating products and systems that no other company can match, and which has created multiple future growth
opportunities. Over the years we have built a substantial barrier to competition through our advanced technological
leadership, which we apply to win and retain customers. This has proven to be a significant competitive differentiator
for Sono-Tek in the global marketplace.
Our environmentally-friendly ultrasonic spray systems provide high performance functional and protective
coatings, with dramatic reductions in overspray, savings in raw materials, water and energy usage, improved
process repeatability, transfer efficiency, high uniformity, and reduced emissions.
Sono-Tek s founder was the inventor of the ultrasonic nozzle and we remain
2023 Annual Report
Fiscal Calendar: March 1st - February 28th
($ in thousands, except employee and per share data)
Net Sales
$ 17,133
$ 14,833
$ 15,355
$ 11,610
Gross Profit
$ 8,613
$ 6,997
$ 7,313
$ 5,249
50.3%
47.2%
47.6%
45.2%
$ 4,994
$ 4,012
$ 4,770
$ 3,841
29.1
27.0
31.1
33.1
$ 1,730
$ 1,645
$ 1,428
$ 1,325
10.1
11.1
9.3
11.4
$ 1,889
$ 1,340
$ 1,115
11.0%
9.0%
7.3%
Gross Margin
Selling, General and Administrative Expense
% of Sales
Research and Product Development Expense
% of Sales
Operating Income
Operating Margin
82
0.7%
Net Income
$ 2,543
$ 1,121
$ 1,107
162
Diluted Earnings Per Share
0.01
Weighted Average Shares Outstanding - Diluted
0.16
0.07
0.07
15,623
15,672
15,359
15,219
Cash, Cash Equivalents and Marketable Securities
$ 10,709
$ 8,648
$ 7,879
$ 5,510
Total Assets
$ 17,626
$ 16,423
$ 14,743
$ 12,200
Total Debt (Long Term)
$ 1,002*
Stockholders Equity
$ 13,741
$ 10,951
$ 9,782
$ 8,585
Book Value Per Share
0.88
0.71
0.64
0.56
0
708
871
Depreciation and Amortization
436
463
407
332
Capital Expenditures
327
344
722
547
Number of Full-Time Employees
*Includes PPP loan, forgiven in Q1 FY2022
67
69
76
68
Backlog at Fiscal Year End
$ in Millions
Revenue
$ in Millions
Gross Margin
2023 Annual Report
7/21/2023 Letter Continued (Full PDF)